维普中文期刊产品整合服务
1篇 您的检索式:作者名="Mukesh Samant"
    题名 作者 年代 出处 被引量
1Identification of SARS-CoV-2 Spike Protein Inhibitors from Urtica dioica to Develop Herbal-Based Therapeutics Against COVID-19显示文摘Objective: The high transmission rate and mutations of SARS-Co V-2 have made it a global pandemic, and the shortage of any effective clinical treatment has created such a commotion. There are some synthetic antiviral drugs, such as remdesivir and lopinavir that are being repurposed to treat SARS-Co V-2, but all of these demonstrate extreme side effects in humans. Hence, promoting herbal-based drug development has become crucial as they are cost-effective and have lesser or no side effects. Urtica dioica is abundant in the Himalayan region and the compounds present in it have shown significant antiviral and anti-SARS activity. Therefore, molecular docking studies were performed to identify SARS-Co V-2 spike protein inhibitors from U. dioica to combat the COVID-19 disease. Materials and Methods: Compounds from U. dioica were screened using the bioinformatic approach, and subsequently, these compounds were docked with the S1 subunit of the COVID-19 spike protein(PDB ID: 6YOR). Molecular docking was carried out using the Py Rx software(0.8 version) and further examined by employing the Discovery Studio Visualizer. Results: About all the selected compounds showed significant binding energy(e.g., beta-sitosterol:-10.3 kcal/mol) in contrast to the control chloroquine phosphate. This binding was observed with the spike protein residues that were common in the old strain and the more contagious newly modified B.1.1.7 strain of SARS-Co V-2. Conclusions: Thus, our study can be used in effective drug development against SARS-Co V-2 and its mutant strains also.Shobha Upreti Jyoti Sankar Prusty Awanish Kumar Mukesh Samant 2023World Journal of Traditional Chinese Medicine2023,9,1:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费